Empleo del capronato de 17-hidroxi-19-norprogesterona como anticonceptivo inyectable de depósito

Hilario Hurtado; Esteban Kesseru; Alfredo Larrañaga

doi:10.31403/rpgo.v14i1457

Capronate use of 17-hydroxy-19-norprogesterone as injectable contraceptive depot.

Authors

Hilario Hurtado Departamento de Ginecología y Obstetricia, Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Perú
Esteban Kesseru Departamento de Ginecología y Obstetricia, Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Perú
Alfredo Larrañaga Departamento de Ginecología y Obstetricia, Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Perú

DOI:

https://doi.org/10.31403/rpgo.v14i1457

Abstract

The authors have studied the contraceptive effect of 17-Alpha Hydroxi-19-Norprogesterona Capronate (SN - 582) in 21 normal women; the effect is present during 6-8 weeks after the inyection of 200 mg. During this time menstrual irregularities as spotting and amenorrhea were observed, but their incidence was lower than those produced by the norethisterone enanthate (SN - 393).

Downloads

Download data is not yet available.

Downloads

PDF (Español (España))

Published

2015-07-20

How to Cite

Hurtado, H., Kesseru, E., & Larrañaga, A. (2015). Capronate use of 17-hydroxy-19-norprogesterone as injectable contraceptive depot. The Peruvian Journal of Gynecology and Obstetrics, 14(2), 223–233. https://doi.org/10.31403/rpgo.v14i1457

Download Citation

Issue

Vol. 14 No. 2 (1968)

Section

Congreso

License

Esta revista provee acceso libre inmediato a su contenido bajo el principio de que hacer disponible gratuitamente la investigación al publico, lo cual fomenta un mayor intercambio de conocimiento global.